About CHF Solutions (NASDAQ:CHFS)
CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CHFS
CUSIPN/A
Phone952-345-4200
Debt
Debt-to-Equity RatioN/A
Current Ratio8.55%
Quick Ratio7.79%
Price-To-Earnings
Trailing P/E Ratio-0.09
Forward P/E Ratio-1.51
P/E GrowthN/A
Sales & Book Value
Annual Sales$3.55 million
Price / Sales3.77
Cash FlowN/A
Price / CashN/A
Book Value$4.27 per share
Price / Book0.74
Profitability
EPS (Most Recent Fiscal Year)($37.15)
Net Income$-13,380,000.00
Net Margins-376.64%
Return on Equity-146.41%
Return on Assets-112.90%
Miscellaneous
Employees46
Outstanding Shares4,230,000
CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions
What is CHF Solutions' stock symbol?
CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS."
When did CHF Solutions' stock split? How did CHF Solutions' stock split work?
CHF Solutions shares reverse split on the morning of Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split.
How were CHF Solutions' earnings last quarter?
CHF Solutions (NASDAQ:CHFS) released its quarterly earnings data on Tuesday, March, 20th. The company reported ($10.00) earnings per share for the quarter. The company had revenue of $0.83 million for the quarter. CHF Solutions had a negative return on equity of 146.41% and a negative net margin of 376.64%. View CHF Solutions' Earnings History.
When is CHF Solutions' next earnings date?
What price target have analysts set for CHFS?
1 analysts have issued 12-month price targets for CHF Solutions' shares. Their forecasts range from $65.00 to $65.00. On average, they expect CHF Solutions' stock price to reach $65.00 in the next twelve months. View Analyst Ratings for CHF Solutions.
Who are some of CHF Solutions' key competitors?
Some companies that are related to CHF Solutions include Kitov Pharma (KTOV), Neuralstem (CUR), Interpace Diagnostics Gr (IDXG), AIT Therapeutics (AITB), Tonix Pharmaceuticals (TNXP), Regenerx Biopharmaceuticals (RGRX), Akari Therapeutics (AKTX), DelMar Pharmaceuticals (DMPI), Akers Biosciences (AKR), ContraVir Pharmaceuticals (CTRV), AEterna Zentaris (AEZS), Dynatronics (DYNT), Neovasc (NVCN), IntelliPharmaCeutics Intl (IPCI), Oncobiologics (ONS), AmpliPhi Biosciences (APHB), EnteroMedics (RSLS) and Cellectar Biosciences (CLRB).
Has CHF Solutions been receiving favorable news coverage?
Headlines about CHFS stock have trended somewhat negative on Thursday, Accern reports. The research group rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CHF Solutions earned a daily sentiment score of -0.03 on Accern's scale. They also gave headlines about the company an impact score of 47.01 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
How do I buy shares of CHF Solutions?
Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CHF Solutions' stock price today?
One share of CHFS stock can currently be purchased for approximately $3.16.
How big of a company is CHF Solutions?
CHF Solutions has a market capitalization of $13.61 million and generates $3.55 million in revenue each year. The company earns $-13,380,000.00 in net income (profit) each year or ($37.15) on an earnings per share basis. CHF Solutions employs 46 workers across the globe.
How can I contact CHF Solutions?
CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected]
MarketBeat Community Rating for CHF Solutions (CHFS)
MarketBeat's community ratings are surveys of what our community members think about CHF Solutions and other stocks. Vote "Outperform" if you believe CHFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHFS will underperform the S&P 500 over the long term. You may vote once every thirty days.
CHF Solutions (NASDAQ:CHFS) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for CHF Solutions in the last 12 months. Their average twelve-month price target is $65.00, suggesting that the stock has a possible upside of 1,956.96%. The high price target for CHFS is $65.00 and the low price target for CHFS is $65.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $65.00 | $65.00 | $65.00 | $32.6150 |
| Price Target Upside: | 1,956.96% upside | N/A | N/A | 13,212.24% upside |
CHF Solutions (NASDAQ:CHFS) Consensus Price Target History
CHF Solutions (NASDAQ:CHFS) Analyst Ratings History
Show:
(Data available from 4/19/2016 forward)
CHF Solutions (NASDAQ:CHFS) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
CHF Solutions (NASDAQ CHFS) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.50%
Institutional Ownership Percentage: 3.91%
CHF Solutions (NASDAQ CHFS) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 10/12/2017 | Ki Yong Choi | Major Shareholder | Buy | 61,645 | $0.52 | $32,055.40 | |  |
| 9/13/2017 | Ki Yong Choi | Major Shareholder | Buy | 78,211 | $0.64 | $50,055.04 | 1,731,464 | |
| 11/28/2016 | John L Erb | CEO | Buy | 80,000 | $0.22 | $17,600.00 | 464,128 | |
| 3/16/2016 | John L Erb | CEO | Buy | 2,500 | $0.91 | $2,275.00 | 381,628 | |
| 3/15/2016 | John L Erb | CEO | Buy | 16,000 | $0.91 | $14,560.00 | 17,628 | |
| 3/14/2016 | John L Erb | CEO | Buy | 8,000 | $0.86 | $6,880.00 | 17,628 | |
| 8/13/2015 | Brian Brown | SVP | Buy | 4,000 | $2.80 | $11,200.00 | | |
| 8/11/2015 | Claudia Drayton | CFO | Buy | 4,000 | $2.57 | $10,280.00 | | |
| 9/15/2014 | Brian Brown | SVP | Buy | 16,000 | $6.01 | $96,160.00 | | |
| 8/28/2014 | William S Peters | Director | Sell | 10,000 | $5.48 | $54,800.00 | | |
| 8/27/2014 | William S Peters | Director | Sell | 5,000 | $5.50 | $27,500.00 | | |
| 3/17/2014 | Jeffrey Mathiesen | CFO | Buy | 2,000 | $6.18 | $12,360.00 | 20,020 | |
| 3/17/2014 | Kevin Bassett | VP | Buy | 1,400 | $6.20 | $8,680.00 | 10,992 | |
| 3/14/2014 | Debra Kridner | VP | Buy | 1,000 | $6.20 | $6,200.00 | 13,584 | |
| 3/13/2014 | William Peters | Director | Sell | 20,000 | $6.20 | $124,000.00 | 13,967 | |
| 1/7/2013 | Straus Asset Management, Llc | Major Shareholder | Sell | 4,750 | $6.19 | $29,402.50 | | |
| 9/14/2012 | Nicholas Callinan | Director | Buy | 2,500 | $9.08 | $22,700.00 | | |
| 8/17/2012 | Donal O'dwyer | Director | Buy | 13,675 | $7.64 | $104,477.00 | | |
(Data available from 1/1/2013 forward)
CHF Solutions (NASDAQ CHFS) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Wired News – Boston Scientific Acquires California-Based nVision Medical
finance.yahoo.com - April 18 at 10:06 AM |
| CHF Solutions, Inc. Expands European Distribution with New Agreement in Italy
finance.yahoo.com - April 17 at 10:03 AM |
 | Critical Analysis: CHF Solutions (CHFS) vs. Its Competitors
www.americanbankingnews.com - April 16 at 3:16 PM |
| Reviewing CHF Solutions (CHFS) and Its Peers
www.americanbankingnews.com - April 16 at 1:12 PM |
| Critical Review: Cutera (CUTR) & CHF Solutions (CHFS)
www.americanbankingnews.com - April 15 at 7:21 AM |
| Analysts Set $15.00 Price Target for CHF Solutions (CHFS)
www.americanbankingnews.com - April 13 at 3:29 AM |
| CHF Solutions, Inc. Expands Operations into Hong Kong; Receives First Commercial Orders for Both Hong Kong and Singapore
finance.yahoo.com - April 12 at 10:53 AM |
| Financial Analysis: CHF Solutions (CHFS) versus Its Rivals
www.americanbankingnews.com - April 12 at 9:08 AM |
| Recently Published CARRESS-HF Per Protocol Analysis Demonstrates Greater Fluid Reduction in Heart Failure Patients Using CHF Solutions’ Aquadex FlexFlow System
finance.yahoo.com - April 10 at 10:17 AM |
| CHF Solutions (CHFS) and The Competition Head-To-Head Review
www.americanbankingnews.com - April 10 at 3:14 AM |
| Sunshine Heart (CHFS) vs. IRIDEX (IRIX) Financial Review
www.americanbankingnews.com - April 8 at 11:36 PM |
| Sunshine Heart (CHFS) Rating Lowered to Strong Sell at ValuEngine
www.americanbankingnews.com - April 8 at 1:28 PM |
| Comparing Sunshine Heart (CHFS) & Its Competitors
www.americanbankingnews.com - April 5 at 7:54 PM |
| CHF Solutions, Inc. Initiates Distribution Agreement in Spain
finance.yahoo.com - April 5 at 8:37 AM |
| Sunshine Heart (CHFS) Upgraded at ValuEngine
www.americanbankingnews.com - April 4 at 12:02 AM |
 | A Family Adventure in the Wild Heart of Tanzania
www.nytimes.com - April 3 at 4:12 PM |
| CHF Solutions to Present at The MicroCap Conference on April 9, 2018
finance.yahoo.com - April 2 at 4:07 PM |
| Sunshine Heart (CHFS) & Its Rivals Financial Analysis
www.americanbankingnews.com - March 31 at 7:16 PM |
| Zacks: Sunshine Heart Inc (CHFS) Given $15.00 Consensus Price Target by Brokerages
www.americanbankingnews.com - March 29 at 9:32 PM |
| CHF Solutions, Inc. Begins New Educational Program, “Facing the Facts About Fluid Overload” to Demonstrate the Need for Aquadex Therapy
finance.yahoo.com - March 29 at 10:30 AM |
| Sunshine Heart (CHFS) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 27 at 7:58 PM |
| Quitting Heroin in the Sunshine State
www.nytimes.com - March 25 at 9:35 AM |
| Contrasting Cardiovascular Systems (CSII) & Sunshine Heart (CHFS)
www.americanbankingnews.com - March 22 at 1:48 PM |
| CHF Solutions, Inc. Announces 11.4 Percent Revenue Growth for its Fourth Quarter and Provides Company Update
finance.yahoo.com - March 20 at 9:51 AM |
| Critical Review: Sunshine Heart (CHFS) and Its Peers
www.americanbankingnews.com - March 20 at 8:46 AM |
| CHF Solutions, Inc. Launches Enhanced Educational Materials to Expand Utilization of the Aquadex FlexFlow System
finance.yahoo.com - March 19 at 10:37 AM |
 | 23 Stocks Moving In Thursday's Pre-Market Session | Benzinga - Benzinga
www.benzinga.com - March 17 at 10:51 AM |
| Sunshine Heart (CHFS) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - March 14 at 12:20 PM |
| Analysts Set $15.00 Target Price for Sunshine Heart Inc (CHFS)
www.americanbankingnews.com - March 13 at 1:30 AM |
| Industry Veteran Carrie Powers Joins CHF Solutions, Inc. as Vice President of Marketing
finance.yahoo.com - March 12 at 4:02 PM |
| CHF Solutions to Exhibit at the 67th Annual Scientific Sessions of the American College of Cardiology
finance.yahoo.com - March 7 at 10:53 AM |
| CHF Solutions to Attend the 30th Annual Roth Conference
finance.yahoo.com - March 6 at 10:18 AM |
| CHF Solutions to Present at the Inaugural LD Micro Virtual Conference
finance.yahoo.com - March 1 at 10:03 AM |
| Zacks: Sunshine Heart Inc (CHFS) Given Consensus Rating of "Strong Buy" by Brokerages
www.americanbankingnews.com - February 24 at 3:38 PM |
| CHF Solutions, Inc. Enhances Commercial Team with the Establishment of a Field Clinical Organization and New Sales Territories
finance.yahoo.com - February 22 at 9:57 AM |
 | We all have everyday heroes -- Here's how mine changed my life
www.foxnews.com - February 19 at 9:42 AM |
| Zacks: Sunshine Heart Inc (CHFS) Given $15.00 Average Price Target by Brokerages
www.americanbankingnews.com - February 16 at 9:28 PM |
| Zacks: Sunshine Heart Inc (CHFS) Given $15.00 Consensus Target Price by Brokerages
www.americanbankingnews.com - February 9 at 9:28 PM |
| CHF Solutions, Inc. To Present at 20th Annual BIO CEO & Investor Conference
finance.yahoo.com - February 8 at 5:48 AM |
| CHF Solutions, Inc. Strengthens Sales Force with Senior Director of US Sales
finance.yahoo.com - February 6 at 3:20 PM |
| CHF Solutions, Inc. Commences In-House Manufacturing of Aquadex FlexFlow Console and Blood Circuits
finance.yahoo.com - January 31 at 3:20 PM |
| Sunshine Heart Inc (CHFS) Receives Average Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - January 25 at 3:30 PM |
| CHF Solutions, Inc. Appoints Vitaliy Epshteyn Vice President of Operations and Engineering
finance.yahoo.com - January 24 at 8:49 AM |
| CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - January 19 at 4:00 PM |
| Zacks Investment Research Lowers Sunshine Heart (CHFS) to Hold
www.americanbankingnews.com - January 18 at 9:16 PM |
| Sunshine Heart (CHFS) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - January 17 at 10:40 PM |
| Zacks Investment Research Downgrades Sunshine Heart (CHFS) to Hold
www.americanbankingnews.com - January 11 at 7:48 PM |
| Sunshine Heart Inc (CHFS) Given $15.00 Consensus Target Price by Brokerages
www.americanbankingnews.com - January 9 at 9:46 PM |
| Sunshine Heart (CHFS) Upgraded at Zacks Investment Research
www.americanbankingnews.com - January 8 at 8:36 PM |
| Sunshine Heart (CHFS) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - January 5 at 7:02 PM |
CHF Solutions (NASDAQ:CHFS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
CHF Solutions (NASDAQ:CHFS) Income Statement, Balance Sheet and Cash Flow Statement
CHF Solutions (NASDAQ CHFS) Stock Chart for Thursday, April, 19, 2018
Loading chart…
